By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Protein research tools firm Abcam today announced it has completed its $6 million buy of MitoSciences.

Abcam, based in Cambridge, UK, paid $4.2 million in cash and issued $1.8 million of Abcam shares at $397.1 pence per share as part of the deal. The purchase will enhance the range of products available to its customers, Abcam said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.